Inhibrx Biosciences, Inc.
Multivalent and Multispecific DR5-Binding Fusion Proteins
Last updated:
Abstract:
The disclosure relates generally to molecules that specifically engage death receptor 5 (DR5), a member of the TNF receptor superfamily (TNFRSF). More specifically the disclosure relates to multivalent and multispecific molecules that bind at least DR5.
Status:
Application
Type:
Utility
Filling date:
5 Aug 2021
Issue date:
3 Mar 2022